This award recognizes excellence in opioid treatment programs and providers who use medications approved by the FDA for the treatment of opioid-related disorders. The award also recognizes providers who have successfully implemented innovative services and/or practices that resulted in improved patient outcomes.
Of particular interest for this award was the implementation of services and practices that support SAMHSA’s priorities in promoting state-of-the art treatment care. These services and practices include the provision, or use of:
- Recovery support services,
- Integrated behavioral and primary health care services,
- Hepatitis prevention and treatment services,
- FDA approved medications for the treatment of opioid dependence,
- Approaches encouraging patient choice in treatment planning, and
- Administrative practices promoting retention, access to care, and service/cost effectiveness and efficiency and electronic health records.
For more information on the winning innovations, please go to: www.samhsa.gov/Scienceandservice/index.aspx
The Substance Abuse and Mental Health Services Administration (SAMHSA) is the agency within the U.S. Department of Health and Human Services that leads public health efforts to advance the behavioral health of the nation. SAMHSA's mission is to reduce the impact of substance abuse and mental illness on America's communities.